Daniel R. Doerge Source Confirmed

OverviewAI-generated summary

Daniel R. Doerge's research investigates the toxicological effects of various compounds and their metabolites, with a particular focus on compounds relevant to human health and environmental exposure. His work includes evaluating the toxicokinetics of polyfluorinated compounds, such as 6:2 fluorotelomer alcohol, in animal models to understand their absorption, distribution, metabolism, and excretion, particularly in pregnant and non-pregnant subjects. He has also studied the biological effects of phytochemicals, including isoliquiritigenin and genistein, examining their roles in processes like bone resorption and their influence on cancer treatment efficacy, such as the response of mammary tumors to tamoxifen.

Doerge's research network includes collaborators from the National Center for Toxicological Research, such as Volodymyr Tryndyak, Frederick A. Beland, Michelle M. Vanlandingham, and Mona I. Churchwell, with whom he has co-authored publications. His scholarly output is substantial, evidenced by 339 total publications and an h-index of 76, with over 19,000 citations. He is recognized as a highly cited researcher, indicating a significant impact in his field. Doerge maintains an active laboratory website, suggesting ongoing research activities and engagement with the scientific community. His recent publications in 2023 demonstrate his continued productivity and relevance in toxicological and pharmacological research.

Metrics

• h-index: 76
• Publications: 339
• Citations: 19,442